-
If you purchased shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), you have certain options and you should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Investigation Overview
August 4, 2015 (Update) - On July 27, 2015, AMAG Pharmaceuticals, Inc stated in its 10Q report that on July 20, 2015, the Federal Trade Commission (the 'FTC') notified AMAG Pharmaceuticals, Inc that it is conducting an investigation with respect to Makena or any hydroxyprogesterone caproate product. AMAG Pharmaceuticals, Inc said that the FTC noted that the existence of the investigat...
You must register (for free) or login to view the entire investigation.
